The observed effects on cancer cell viability, migration, and morphological integrity following ESM1 knockdown align with the therapeutic goals pursued in other cancer types, marking a milestone in the journey towards targeted treatment strategies for thyroid cancer. This evidence concerns the gene ESM1 and thyroid gland carcinoma.